The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
 
Steven G. DuBois
Honoraria - Loxo
Research Funding - Merck (Inst); Millennium (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Loxo
 
Araz Marachelian
Honoraria - United Therapeutics
 
Elizabeth Fox
Research Funding - Millennium (Inst)
 
Rachel A. Kudgus
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Susan G. Groshen
Employment - Pfizer (I)
 
Jemily Malvar
No Relationships to Disclose
 
Rochelle Bagatell
No Relationships to Disclose
 
Lars M. Wagner
No Relationships to Disclose
 
John M. Maris
Research Funding - GlaxoSmithKline; Novartis
 
Randall Hawkins
No Relationships to Disclose
 
Jesse Courtier
No Relationships to Disclose
 
Hollie Lai
No Relationships to Disclose
 
Fariba Goodarzian
No Relationships to Disclose
 
Hiroyuki Shimada
No Relationships to Disclose
 
Najee Boucher
No Relationships to Disclose
 
Scarlett Czarnecki
No Relationships to Disclose
 
Denice D Tsao-Wei
No Relationships to Disclose
 
Katherine K. Matthay
No Relationships to Disclose
 
Yael P. Mosse
No Relationships to Disclose